Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00183976 · ClinicalTrials.gov registry record · Phase 2
Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas
A Phase 2 study, sponsored by University of Southern California.
- Terminated
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT00183976: Clinical Trial Phase 2 study, sponsored by University of Southern California.
NCT00183976 is a Phase 2 study that was terminated before completion, run by University of Southern California. The registered enrollment target is 15 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00183976, a Phase 2 study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study is for patients who have been treated before and either the treatment did not work or the lymphoma has come back.
Interventions
- DRUG Pegylated Liposomal Doxorubicin (Doxil) and Rituximab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2005-04 |
| Est. Completion | 2006-01 |
| Phase | Phase 2 |
Why NCT00183976 stopped before completion
NCT00183976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Pegylated Liposomal Doxorubicin (Doxil) and Rituximab is the first listed.
NCT00183976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00183976 about?
NCT00183976 is a clinical study titled "Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas". This study is for patients who have been treated before and either the treatment did not work or the lymphoma has come back.
What is the current status of trial NCT00183976?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2005-04. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00183976?
The interventions under investigation include: Pegylated Liposomal Doxorubicin (Doxil) and Rituximab (DRUG).
Who is sponsoring clinical trial NCT00183976?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00183976's enrollment target sits among peer trials
15 1919th of 2000 higher than 60 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia